The Berlin Retinopathy Study follows children from the onset of diabetes with serial retinal examinations by fluorescein angiography. It confirmed that long-term poor glycemic control, both before and after puberty, is the major risk factor for the development of retinal changes. The relationship between long-term HbA1c and background retinopathy follows an exponential, non-linear function. Apart from glycemia, several other factors (age at onset, puberty, lipids, blood pressure, genetic factors, smoking) may be of varying relevance in the individual patient. Nevertheless, best glycemic control from the onset of diabetes appears to be of outstanding importance as the HbA1c levels already during the first year of diabetes are related to the later development of background retinopathy.

Keywords:
Retinopathy, Puberty, HbA1c, Glycemic threshold
1.
Danne T, Kordonouri O, Hövener G, Weber B: Diabetic angiopathy in children. Diabetes Med 1997;14:1012–1025.
2.
Danne T, Kordonouri O, Enders I, Hövener G: Monitoring for retinopathy in children and adolescents with type 1 diabetes mellitus. Acta Paediatr 1998; in press.
3.
Burger W, Hövener G, Düsterhus R, Hartmann R, Weber B: Prevalence and development of retinopathy in children and adolescents with diabetes mellitus: A longitudinal study. Diabetologia 1986;29:17–22.
4.
Danne T, Weber B, Hartmann R, Enders I, Burger W, Hövener G: Longterm glycaemic control has a nonlinear association to the frequency of background retinopathy in adolescents with type I diabetes: Follow-up of the Berlin Retinopathy Study. Diabetes Care 1994;17:1390–1396.
5.
Burger W, Weber B, Enders I, Hartmann R: Therapy of diabetes mellitus in children and adolescents: aims, criteria, results. Monatschr Kinderheilkd 1991;139:62–68.
6.
Danne T, Kordonouri O, Hövener G, Weber B: Is ophthalmoscopy via a dilated pupil sufficient to detect retinopathy in adolescents with diabetes? (abstract). JPEM 1997; 10:332.
7.
KROC Collaborative Study Group: Diabetic retinopathy after two years of intensified treatment. JAMA 1988;260:37–41.
8.
Brinchmann-Hansen O, Dahl-Jorgensen K, Sanvik L, Hanssen KF: Blood glucose concentrations and progression of diabetic retinopathy: The seven years results of the Oslo Study. BMJ 1992;304:19–22.
9.
Norgaard K, Storm B, Grae M, Feldt-Rasmussen B: Elevated albumin excretion and retinal changes in children with type I diabetes are related to long-term poor blood glucose control. Diabetes Med 1989;6:325–328.
10.
DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986.
11.
DCCT Research Group: Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994;125:177–188.
12.
Danne T, Weber B, Dinesen B, Mortensen HB: Threshold of HbA1c for the effect of hyperglycemia on the risk of diabetic microangiopathy (letter). Diabetes Care 1996;19:183.
13.
Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH. Glycosylated haemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995;332:1251–1255.
14.
Mathiesen ER, Ronn B, Strom B, Foght V, Deckert T: The natural course of microalbuminuria in insulin-dependent diabetes: A ten-year prospective study. Diabetic Med 1995;12:482–487.
15.
Nagaraj RH, Kern TS, Sell DB, Fogarty J, Engerman RL, Monnier VM: Evidence of a glycaemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen. Diabetes 1996;45:587–594.
16.
DCCT Research Group: The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial. Diabetes 1996;45:1289–1298.
17.
Kovacs M, Mukerji P, Drash A, Iyengar S: Biomedical and psychiatric risk factors for retinopathy among children with IDDM. Diabetes Care 1995;18:1592–1599.
18.
Weber B, Burger W, Hartmann R, Hövener G, Malchus R, Oberdisse U: Risk faktors for the development of retinopathy in children and adolescents with type I (insulin-dependent) diabetes. Diabetologia 1986;29:23–29.
19.
Kordonouri O, Danne T, Hopfenmüller W, Enders I, Hövener G, Weber B: Lipid profiles and blood pressure: Are they risk factors for the developemt of early background retinopathy and incipient nephropathy in children with insulin-dependent diabetes mellitus? Acta Paediatr 1996;85:43–48.
20.
Chase HP, Garg SK, Jackson WE, Thomas MA, Harris S, Marshall G, Crews MJ: Blood pressure and retinopathy in type I diabetes. Ophthalmology 1990;97:155–159.
21.
Marshall G, Garg SK, Jackson WE, Holmes DL, Chase HP: Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus. Ophthalmology 1993;100:1133–1139.
22.
The Diabetes Control and Complications Study Group. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 1997;46:1829–1839.
23.
Kostraba JN, Dorman JS, Orchard TJ, Becker DJ, Ohki Y, Ellis D, Doft BH, Lobes LA, LaPorte RE, Drash AL: Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care 1989;12:686–693.
24.
Kordonouri O, Danne T, Hartmann R, Enders I, Weber B: Influence of age and pubertal stage at IDDM onset on longterm metabolic control and development of early background retinopathy (abstract). JPEM 1996;9:217.
25.
McNally PG, Raymond NT, Swift PGF, Hearnshaw JR, Burden AC: Does the prepubertal duration of diabetes influence the onset of microvascular complications? Diab Med 1993;10:905.
26.
Algvere P: Prepubertal diabetes duration increases the risk of retinopathy. Acta Paediatr 1994;83:341.
27.
Burger W, Hartmann R, Hövener G, Danne T, Weber B: Realistic objectives and rational approaches to the treatment of children and adolescents with diabetes aiming at the prevention of secondary complications; in Weber B, Burger W, Danne T (eds): in Structural and Functional Abnormalities in Subclinical Diabetic Angiopathy. Pediatr Adolesc Endocr. Basel, Karger, 1992, vol 22, pp 210–219.
28.
Danne T, Kordonouri O, Enders I, Weber B: Factors influencing height and weight in children with diabetes. Results of the Berlin Retinopathy Study. Diabetes Care 1997;20:281–285.
29.
Rudberg S, Ullman E, Dahlquist G: Relationship between early metabolic control and the development of microalbuminuria – a longitudinal study in children with type 1 (insulin-dependent) diabetes. Diabetologia 1993;36:1309–1314.
30.
Merimee TJ: A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes. N Engl J Med 1978;298:1217–1222.
31.
L’Esperance FA, James WA: Pituitary ablation; in L’Esperance FA, James WA (eds): Diabetic Retinopathy. London, Mosby, 1981, pp 132–145.
32.
Williamson JR, Rowold E, Chang K, Marvel J, Tomlinson M, Sherman WR, Ackermann KE, Berger RA, Kilo C: Sex steroid dependency of diabetes-induced changes in polyol metabolism, vascular permeability, and collagen cross-linking. Diabetes 1986;35:20–27.
33.
Rogers DG, White NH, Shalwitz RA, Palmberg P, Smith ME, Santiago JV: The effect of puberty on the development of early diabetic microvascular disease in insulin-dependent diabetes. Diab Res Clin Pract 1987;3:39–44.
34.
Murphy RP, Nanda M, Plotnick L, Enger C, Vitale S, Patz A: The relationship of puberty to diabetic retinopathy. Arch Ophthalmol 1990;108:215–218.
35.
Kernell A, Dedorsson I, Johansson B, Wickström CP, Ludvigsson J, Tuvemo T, et al: Prevalence of diabetic retinopathy in children and adolescents with IDDM. Diabetologia 1997;40:307–310.
36.
Bonney M, Hing SJ, Fung AT, Stephens MM, Fairchild JM, Donaghue KC, Howard NJ, Silink M: Development and progression of diabetic retinopathy: Adolescents at risk. Diabetic Med 1995;12:967–973.
37.
Klein BEK, Moss SE, Klein R: Is menarchy associated with retinopathy? Diabetes Care 1990;13:1034–1038.
38.
Goldstein DE, Blinder KJ, Ide CH, Wilson RJ, Wiedmeyer HM, Little RR, England JD, Eddy M, Hewett JE, Anderson SK: Glycaemic control and development of retinopathy in youth-onset insulin-dependent diabetes mellitus. Ophthalmology 1993;100:1125–1132.
39.
Weber B: Wenn die Inseln untergeh’n: Diabetes mellitus bei Kindern, eine permanente Herausforderung für Ärzte und Gesellschaft. Diabetes Stoffwechsel 1997;6:210–222.
40.
Daneman D, Knip M, Kaar ML, Sochett E: Comparison of children with type 1 (insulin-dependent) diabetes in northern Finland and southern Ontario: Differences at disease onset. Diabetes Res 1990;14:123–126.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.